Renal Specialist Takes Up Hypertension Fight

By Petrina Smith
Monday, 08 December, 2014


Renal physician and hypertension specialist Professor Markus Schlaich has been appointed inaugural Dobney Chair in Clinical Research, a position co-funded by UWA, Royal Perth Hospital and the Royal Perth Hospital Medical Research Foundation.
In this new position, Professor Schlaich will spearhead efforts to develop preventive strategies to reduce death and disability from cardiovascular disease, which is an enormous burden on health and society. Professor Shlaich said  there are more than 30 per cent of Australians affected by high blood pressure and 8.5 million deaths each year worldwide, directly attributable to uncontrolled blood pressure.
“Better research programs to identify the underlying causes and developing more successful therapeutic strategies are key to reducing the burden of cardiovascular disease. “The role of the sympathetic nervous system in the development of hypertension and novel therapeutic approaches to specifically target these overactive nerves must be a major research focus.
“The fact that a large number of patients with hypertension don’t stick to their prescribed blood pressure-
lowering medication is another important clinical challenge that needs to be addressed,” Professor Schlaich said.
The position is the result of a strong partnership forged over many years between UWA, RPH and the RPH Medical Research Foundation. Funding of almost $6.5 million over seven years will provide for the Chair as well as a postdoctoral research fellow, a nurse manager, a research officer, a part- time executive assistant and a set-up grant.
Professor Schlaich, an NHMRC Senior Research Fellow, was previously working at the Baker IDI Heart and Diabetes Research Institute in Melbourne, where he was head of the neurovascular hypertension and kidney disease laboratory. He has received many research prizes and awards for his work, including the Australian Museum Eureka Prize for Medical Research Translation, and has served on the executive committee of the High Blood Pressure Research Council of Australia.
Ray Dobney was a long–term cancer patient at RPH and generous donor to the RPH Medical Research Foundation, which co-funds the chair package.

Related News

NSW sepsis pathway outperforms international model

The NSW model is more likely to trigger a warning of patient deterioration from sepsis than the...

Safe nCov coronavirus vaccine may take years

The claims of multiple vaccine developers that an nCov coronavirus vaccine may soon be in our...

Australian-led trial in ASCO's Progress Against Cancer report

A trial conducted by an Australian and New Zealand research group has been recognised as one of...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd